| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |